 | • レポートコード：QYR9ST00227 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の肺薬市場について調査・分析し、以下の構成でお届け致します。肺薬の種類別には、吸入コルチコステロイド、長時間作用型ベータ2作動薬、抗ヒスタミン薬、血管拡張薬、その他に、用途別には、喘息及びCOPD、アレルギー性鼻炎、肺動脈高血圧症、嚢胞性線維症、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別肺薬売上データ ・地域別肺薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別肺薬市場規模：吸入コルチコステロイド、長時間作用型ベータ2作動薬、抗ヒスタミン薬、血管拡張薬、その他 ・用途別肺薬市場規模：喘息及びCOPD、アレルギー性鼻炎、肺動脈高血圧症、嚢胞性線維症、その他 ・主要メーカーの企業情報：Sanofi SA、Meda Pharmaceuticals、Circassia Pharmaceuticals Plc.、AstraZeneca Plc.、GlaxoSmithKline Plc.、Mallinckrodt Pharmaceuticals Plc.、Cheisi Farmaceutici S.p.A、Zambon Company S.p.A、Alaxia SAS、Merck Sharp & Dohme Limited ・肺薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
The pulmonary drugs are used for treating the conditions affecting lungs. The pulmonary drugs are used from treating minor illnesses such as the common cold to cure long-term disorders such asthma. These agents are available in different forms such as oral tablets, oral liquids, and injections or inhalations. Inhalations deliver the medicine directly to the lungs, which can act directly on the lung tissues, minimizing systemic side effects.The major factors driving growth of the pulmonary drugs market include increasing incidence of chronic respiratory diseases, tobacco smoking, and government and non-government initiatives.
The global Pulmonary Drugs market is valued at 30400 million US$ in 2018 and will reach 56600 million US$ by the end of 2025, growing at a CAGR of 8.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pulmonary Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Pulmonary Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pulmonary Drugs in these regions.
This research report categorizes the global Pulmonary Drugs market by top players/brands, region, type and end user. This report also studies the global Pulmonary Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Sanofi SA
Meda Pharmaceuticals
Circassia Pharmaceuticals Plc.
AstraZeneca Plc.
GlaxoSmithKline Plc.
Mallinckrodt Pharmaceuticals Plc.
Cheisi Farmaceutici S.p.A
Zambon Company S.p.A
Alaxia SAS
Merck Sharp & Dohme Limited
Market size by Product
Inhaled Corticosteroids
Long Acting Beta-2 Agonists
Antihistamines
Vasodilators
Others
Market size by End User
Asthma & COPD
Allergic Rhinitis
Pulmonary Arterial Hypertension
Cystic Fibrosis
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Pulmonary Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Pulmonary Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pulmonary Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Pulmonary Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Pulmonary Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pulmonary Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Pulmonary Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pulmonary Drugs Market Size Growth Rate by Product
1.4.2 Inhaled Corticosteroids
1.4.3 Long Acting Beta-2 Agonists
1.4.4 Antihistamines
1.4.5 Vasodilators
1.4.6 Others
1.5 Market by End User
1.5.1 Global Pulmonary Drugs Market Size Growth Rate by End User
1.5.2 Asthma & COPD
1.5.3 Allergic Rhinitis
1.5.4 Pulmonary Arterial Hypertension
1.5.5 Cystic Fibrosis
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pulmonary Drugs Market Size
2.1.1 Global Pulmonary Drugs Revenue 2014-2025
2.1.2 Global Pulmonary Drugs Sales 2014-2025
2.2 Pulmonary Drugs Growth Rate by Regions
2.2.1 Global Pulmonary Drugs Sales by Regions
2.2.2 Global Pulmonary Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Pulmonary Drugs Sales by Manufacturers
3.1.1 Pulmonary Drugs Sales by Manufacturers
3.1.2 Pulmonary Drugs Sales Market Share by Manufacturers
3.1.3 Global Pulmonary Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Pulmonary Drugs Revenue by Manufacturers
3.2.1 Pulmonary Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Pulmonary Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Pulmonary Drugs Price by Manufacturers
3.4 Pulmonary Drugs Manufacturing Base Distribution, Product Types
3.4.1 Pulmonary Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pulmonary Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Pulmonary Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Pulmonary Drugs Sales by Product
4.2 Global Pulmonary Drugs Revenue by Product
4.3 Pulmonary Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Pulmonary Drugs Breakdown Data by End User
6 North America
6.1 North America Pulmonary Drugs by Countries
6.1.1 North America Pulmonary Drugs Sales by Countries
6.1.2 North America Pulmonary Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Pulmonary Drugs by Product
6.3 North America Pulmonary Drugs by End User
7 Europe
7.1 Europe Pulmonary Drugs by Countries
7.1.1 Europe Pulmonary Drugs Sales by Countries
7.1.2 Europe Pulmonary Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pulmonary Drugs by Product
7.3 Europe Pulmonary Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Pulmonary Drugs by Countries
8.1.1 Asia Pacific Pulmonary Drugs Sales by Countries
8.1.2 Asia Pacific Pulmonary Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Pulmonary Drugs by Product
8.3 Asia Pacific Pulmonary Drugs by End User
9 Central & South America
9.1 Central & South America Pulmonary Drugs by Countries
9.1.1 Central & South America Pulmonary Drugs Sales by Countries
9.1.2 Central & South America Pulmonary Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Pulmonary Drugs by Product
9.3 Central & South America Pulmonary Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Pulmonary Drugs by Countries
10.1.1 Middle East and Africa Pulmonary Drugs Sales by Countries
10.1.2 Middle East and Africa Pulmonary Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Pulmonary Drugs by Product
10.3 Middle East and Africa Pulmonary Drugs by End User
11 Company Profiles
11.1 Sanofi SA
11.1.1 Sanofi SA Company Details
11.1.2 Company Business Overview
11.1.3 Sanofi SA Pulmonary Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Sanofi SA Pulmonary Drugs Products Offered
11.1.5 Sanofi SA Recent Development
11.2 Meda Pharmaceuticals
11.2.1 Meda Pharmaceuticals Company Details
11.2.2 Company Business Overview
11.2.3 Meda Pharmaceuticals Pulmonary Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Meda Pharmaceuticals Pulmonary Drugs Products Offered
11.2.5 Meda Pharmaceuticals Recent Development
11.3 Circassia Pharmaceuticals Plc.
11.3.1 Circassia Pharmaceuticals Plc. Company Details
11.3.2 Company Business Overview
11.3.3 Circassia Pharmaceuticals Plc. Pulmonary Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Circassia Pharmaceuticals Plc. Pulmonary Drugs Products Offered
11.3.5 Circassia Pharmaceuticals Plc. Recent Development
11.4 AstraZeneca Plc.
11.4.1 AstraZeneca Plc. Company Details
11.4.2 Company Business Overview
11.4.3 AstraZeneca Plc. Pulmonary Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 AstraZeneca Plc. Pulmonary Drugs Products Offered
11.4.5 AstraZeneca Plc. Recent Development
11.5 GlaxoSmithKline Plc.
11.5.1 GlaxoSmithKline Plc. Company Details
11.5.2 Company Business Overview
11.5.3 GlaxoSmithKline Plc. Pulmonary Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 GlaxoSmithKline Plc. Pulmonary Drugs Products Offered
11.5.5 GlaxoSmithKline Plc. Recent Development
11.6 Mallinckrodt Pharmaceuticals Plc.
11.6.1 Mallinckrodt Pharmaceuticals Plc. Company Details
11.6.2 Company Business Overview
11.6.3 Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Products Offered
11.6.5 Mallinckrodt Pharmaceuticals Plc. Recent Development
11.7 Cheisi Farmaceutici S.p.A
11.7.1 Cheisi Farmaceutici S.p.A Company Details
11.7.2 Company Business Overview
11.7.3 Cheisi Farmaceutici S.p.A Pulmonary Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Cheisi Farmaceutici S.p.A Pulmonary Drugs Products Offered
11.7.5 Cheisi Farmaceutici S.p.A Recent Development
11.8 Zambon Company S.p.A
11.8.1 Zambon Company S.p.A Company Details
11.8.2 Company Business Overview
11.8.3 Zambon Company S.p.A Pulmonary Drugs Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Zambon Company S.p.A Pulmonary Drugs Products Offered
11.8.5 Zambon Company S.p.A Recent Development
11.9 Alaxia SAS
11.9.1 Alaxia SAS Company Details
11.9.2 Company Business Overview
11.9.3 Alaxia SAS Pulmonary Drugs Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Alaxia SAS Pulmonary Drugs Products Offered
11.9.5 Alaxia SAS Recent Development
11.10 Merck Sharp & Dohme Limited
11.10.1 Merck Sharp & Dohme Limited Company Details
11.10.2 Company Business Overview
11.10.3 Merck Sharp & Dohme Limited Pulmonary Drugs Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Merck Sharp & Dohme Limited Pulmonary Drugs Products Offered
11.10.5 Merck Sharp & Dohme Limited Recent Development
12 Future Forecast
12.1 Pulmonary Drugs Market Forecast by Regions
12.1.1 Global Pulmonary Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Pulmonary Drugs Revenue Forecast by Regions 2019-2025
12.2 Pulmonary Drugs Market Forecast by Product
12.2.1 Global Pulmonary Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Pulmonary Drugs Revenue Forecast by Product 2019-2025
12.3 Pulmonary Drugs Market Forecast by End User
12.4 North America Pulmonary Drugs Forecast
12.5 Europe Pulmonary Drugs Forecast
12.6 Asia Pacific Pulmonary Drugs Forecast
12.7 Central & South America Pulmonary Drugs Forecast
12.8 Middle East and Africa Pulmonary Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pulmonary Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Pulmonary Drugs Product Picture
Table Pulmonary Drugs Market Segments
Table Key Manufacturers Pulmonary Drugs Covered
Table Global Pulmonary Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Pulmonary Drugs Sales Market Share by Product 2014-2025
Figure Inhaled Corticosteroids Product Picture
Table Major Manufacturers of Inhaled Corticosteroids
Figure Long Acting Beta-2 Agonists Product Picture
Table Major Manufacturers of Long Acting Beta-2 Agonists
Figure Antihistamines Product Picture
Table Major Manufacturers of Antihistamines
Figure Vasodilators Product Picture
Table Major Manufacturers of Vasodilators
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Pulmonary Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Asthma & COPD
Figure Allergic Rhinitis
Figure Pulmonary Arterial Hypertension
Figure Cystic Fibrosis
Figure Others
Figure Pulmonary Drugs Report Years Considered
Figure Global Pulmonary Drugs Market Size 2014-2025 (Million US$)
Figure Global Pulmonary Drugs Sales 2014-2025 (K Units)
Table Global Pulmonary Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Pulmonary Drugs Sales by Regions 2014-2019 (K Units)
Table Global Pulmonary Drugs Sales Market Share by Regions 2014-2019
Figure Global Pulmonary Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Pulmonary Drugs Sales Market Share by Regions
Table Global Pulmonary Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Pulmonary Drugs Revenue Market Share by Regions 2014-2019
Figure Global Pulmonary Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Pulmonary Drugs Revenue Market Share by Regions
Table Global Pulmonary Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Pulmonary Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Pulmonary Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Pulmonary Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Pulmonary Drugs Revenue Share by Manufacturers (2014-2019)
Figure Pulmonary Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Pulmonary Drugs Price (2014-2019) (USD/Unit)
Table Pulmonary Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Pulmonary Drugs Product Type
Table Date of International Manufacturers Enter into Pulmonary Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Pulmonary Drugs Sales by Product (2014-2019) (K Units)
Table Global Pulmonary Drugs Sales Share by Product (2014-2019)
Figure Global Pulmonary Drugs Sales Market Share by Product (2014-2019)
Figure Global Pulmonary Drugs Sales Market Share by Product in 2018
Table Global Pulmonary Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Pulmonary Drugs Revenue Share by Product (2014-2019)
Figure Global Pulmonary Drugs Revenue Market Share by Product (2014-2019)
Figure Global Pulmonary Drugs Revenue Market Share by Product in 2018
Table Pulmonary Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Pulmonary Drugs Sales by End User (2014-2019) (K Units)
Table Global Pulmonary Drugs Sales Share by End User (2014-2019)
Figure Global Sales Pulmonary Drugs Market Share by End User (2014-2019)
Figure Global Sales Pulmonary Drugs Market Share by End User in 2018
Figure North America Pulmonary Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Pulmonary Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Pulmonary Drugs Sales by Countries (2014-2019) (K Units)
Table North America Pulmonary Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Pulmonary Drugs Sales Market Share by Countries
Table North America Pulmonary Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Pulmonary Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Pulmonary Drugs Revenue Market Share by Countries
Figure United States Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Pulmonary Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Pulmonary Drugs Sales by Product (2014-2019) (K Units)
Table North America Pulmonary Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Pulmonary Drugs Market Share by Product
Table North America Pulmonary Drugs Sales by End User (2014-2019) (K Units)
Table North America Pulmonary Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Pulmonary Drugs Market Share by End User
Figure Europe Pulmonary Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Pulmonary Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Pulmonary Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Pulmonary Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Pulmonary Drugs Sales Market Share by Countries
Table Europe Pulmonary Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Pulmonary Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Pulmonary Drugs Revenue Market Share by Countries
Figure Germany Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Pulmonary Drugs Sales by Product (2014-2019) (K Units)
Table Europe Pulmonary Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Pulmonary Drugs Market Share by Product
Table Europe Pulmonary Drugs Sales by End User (2014-2019) (K Units)
Table Europe Pulmonary Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Pulmonary Drugs Market Share by End User
Figure Asia Pacific Pulmonary Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Pulmonary Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Pulmonary Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Pulmonary Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Pulmonary Drugs Sales Market Share by Countries
Table Asia Pacific Pulmonary Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Pulmonary Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Pulmonary Drugs Revenue Market Share by Countries
Figure China Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Pulmonary Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Pulmonary Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Pulmonary Drugs Market Share by Product
Table Asia Pacific Pulmonary Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Pulmonary Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Pulmonary Drugs Market Share by End User
Figure Central & South America Pulmonary Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Pulmonary Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Pulmonary Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Pulmonary Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Pulmonary Drugs Sales Market Share by Countries
Table Central & South America Pulmonary Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Pulmonary Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Pulmonary Drugs Revenue Market Share by Countries
Figure Brazil Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Pulmonary Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Pulmonary Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Pulmonary Drugs Market Share by Product
Table Central & South America Pulmonary Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Pulmonary Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Pulmonary Drugs Market Share by End User
Figure Middle East and Africa Pulmonary Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Pulmonary Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Pulmonary Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Pulmonary Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Pulmonary Drugs Sales Market Share by Countries
Table Middle East and Africa Pulmonary Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Pulmonary Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Pulmonary Drugs Revenue Market Share by Countries
Figure GCC Countries Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Pulmonary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Pulmonary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Pulmonary Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Pulmonary Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Pulmonary Drugs Market Share by Product
Table Middle East and Africa Pulmonary Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Pulmonary Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Pulmonary Drugs Market Share by End User
Table Sanofi SA Company Details
Table Sanofi SA Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi SA Recent Development
Table Meda Pharmaceuticals Company Details
Table Meda Pharmaceuticals Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Meda Pharmaceuticals Recent Development
Table Circassia Pharmaceuticals Plc. Company Details
Table Circassia Pharmaceuticals Plc. Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Circassia Pharmaceuticals Plc. Recent Development
Table AstraZeneca Plc. Company Details
Table AstraZeneca Plc. Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Plc. Recent Development
Table GlaxoSmithKline Plc. Company Details
Table GlaxoSmithKline Plc. Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Plc. Recent Development
Table Mallinckrodt Pharmaceuticals Plc. Company Details
Table Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Mallinckrodt Pharmaceuticals Plc. Recent Development
Table Cheisi Farmaceutici S.p.A Company Details
Table Cheisi Farmaceutici S.p.A Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Cheisi Farmaceutici S.p.A Recent Development
Table Zambon Company S.p.A Company Details
Table Zambon Company S.p.A Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Zambon Company S.p.A Recent Development
Table Alaxia SAS Company Details
Table Alaxia SAS Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Alaxia SAS Recent Development
Table Merck Sharp & Dohme Limited Company Details
Table Merck Sharp & Dohme Limited Pulmonary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Sharp & Dohme Limited Recent Development
Table Global Pulmonary Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Pulmonary Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Pulmonary Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Pulmonary Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Pulmonary Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Pulmonary Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Pulmonary Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Pulmonary Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Pulmonary Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Pulmonary Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Pulmonary Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Pulmonary Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Pulmonary Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Pulmonary Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Pulmonary Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Pulmonary Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Pulmonary Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Pulmonary Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Pulmonary Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Pulmonary Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Pulmonary Drugs Value Chain
Table Pulmonary Drugs Customers List
Table Pulmonary Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
肺動脈性肺高血圧症治療の世界市場：インサイト・予測 Pulmonary arterial hypertension- commonly known as PAH- is characterized by increased pressure in the pulmonary arteries due to structural changes in blood vessel walls, aggregation of platelets and alteration of smooth muscle cell function- eventually elevating pressure in the pulmonary arteries re…- 喘息及びCOPD薬の世界市場：インサイト・予測 Asthma is a chronic respiratory disease blocking the airways of lung because of inflammation, mucus production, tighten of muscles. Chronic Obstructive Pulmonary Disease(COPD) is caused by obstruction in the airways causing difficulty in breathing, with the primary cause as tobacco smoking.The Globa…
- 肺拡張バルーンの世界市場：インサイト・予測 The pulmonary dilation balloon is a technique used in the treatment of pulmonary valve stenosis. Pulmonary valve stenosis is an abnormality in which there is some deformity on or in the vicinity of the pulmonary valve, and this abnormality slows the blood flow. The global Pulmonary Dilation Balloon …
- 慢性閉塞性肺疾患の世界市場：市場規模・現状・予測 Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time.The…
- 特発性肺線維症の世界市場：市場規模・現状・予測 Idiopathic pulmonary fibrosis is a condition in which the tissues in the lungs become thick and stiff over time. As a result of thickening of lung tissues, brain and other organs are unable receive optimum oxygen.An increase in the incidence and prevalence of fibrotic diseases is the primary driver …